To verify whether the studied biomarkers are dependent on the known prognostic factors for breast cancer, their expression was compared with the following prognostic factors: histological grade, TNM classification, lymph node status, and the expression of ER, PR, Ki67, and HER2. This evidence concerns the gene ERBB2 and breast carcinoma.